<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diuretics and calcium balance</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diuretics and calcium balance</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Diuretics and calcium balance</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard H Sterns, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Emmett, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert Q Lam, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 13, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Most of the filtered calcium is reabsorbed throughout the nephron. This process involves two basic steps: (1) calcium is reabsorbed passively in the proximal tubule and loop of Henle down the favorable electrochemical gradients created by sodium and water reabsorption; and (2) calcium transport is actively regulated according to changes in calcium balance in the distal tubule and adjacent connecting segment (a small segment between the distal tubule and cortical collecting tubule) [<a href="#rid1">1,2</a>]. Parathyroid hormone (PTH) and calcitriol, the most active form of vitamin D, which may act in part by enhancing the activity of PTH, appear to stimulate this active process [<a href="#rid1">1,3,4</a>].</p><p>Calcium reabsorption and urinary calcium excretion can be affected by the administration of diuretics. Calcium excretion is increased by loop diuretics and diminished by thiazide-type diuretics and <a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">amiloride</a>. How these effects occur is related to the mechanisms of sodium, chloride, and calcium transport in the different diuretic-sensitive segments. Ions cannot directly cross epithelial cell membranes. As a result, transcellular reabsorption of ions requires either the presence of transmembrane carriers or channels [<a href="#rid5">5</a>] or passage through the paracellular space between the tubular cells.</p><p class="headingAnchor" id="H2233653171"><span class="h1">PROXIMAL TUBULE</span><span class="headingEndMark"> — </span>Calcium that is not bound to protein (approximately one-half of the calcium in plasma) is filtered at the glomerulus, and approximately two-thirds of the filtered calcium is reabsorbed in the proximal tubule. Most proximal reabsorption is a passive paracellular process, driven by active sodium transport, which creates an osmotic gradient across the leaky proximal tubular epithelium that results in water (and calcium) reabsorption. Paracellular permeability of the proximal tubule to calcium depends on paracellular pores, composed of claudin proteins. There is evidence that claudin 2 provides a paracellular calcium pore to the proximal tubule [<a href="#rid6">6</a>]. Claudin 2 deficiency in mice results in increased urinary calcium excretion, and common genetic variants in the claudin 2 gene are associated with decreased tissue expression of claudin 2 and an increased risk of kidney stones [<a href="#rid6">6</a>]. </p><p>Osmotic diuretics such as <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> interfere with paracellular water reabsorption from the proximal tubule and increase fractional excretion of calcium [<a href="#rid7">7</a>]. Sodium reabsorption in the proximal tubule occurs primarily through sodium-hydrogen exchange, which then creates an osmotic force across the leaky proximal tubular epithelium that drives water. The carbonic anhydrase inhibitor <a class="drug drug_general" data-topicid="9268" href="/d/drug information/9268.html" rel="external">acetazolamide</a>, which impairs sodium-hydrogen exchange, increases urinary calcium excretion [<a href="#rid7">7</a>]. Inhibitors of sodium-glucose co-transporter 2 (SGLT-2), which are increasingly used to treat diabetes, block sodium-glucose co-transport in the proximal tubule, eliciting a glucose-induced osmotic diuresis. As a result, SGLT-2 inhibitors decrease the luminal calcium concentration that drives paracellular calcium reabsorption in the proximal tubule. Decreased proximal reabsorption of calcium is the likely mechanism for the increase in calcium excretion caused by these agents [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H2"><span class="h1">LOOP OF HENLE AND LOOP DIURETICS</span><span class="headingEndMark"> — </span>Filtered sodium chloride enters the cells in the thick ascending limb of the loop of Henle via <strong>Na-K-2Cl</strong> cotransporters in the luminal (or apical) membrane (<a class="graphic graphic_figure graphicRef75301" href="/d/graphic/75301.html" rel="external">figure 1</a>) [<a href="#rid5">5,9,10</a>]. Although this process is electrically neutral, most of the reabsorbed potassium leaks back into the lumen to drive further sodium chloride transport [<a href="#rid4">4</a>]. This movement of cationic potassium into the lumen plus the movement of reabsorbed chloride (via a chloride channel) out of the cell into the peritubular capillary generates a net positive current from the capillary into the lumen. The ensuing lumen electropositivity creates an electrical gradient that promotes the passive reabsorption of cations (sodium and, to a lesser degree, calcium and magnesium) via the paracellular pathway between the cells [<a href="#rid11">11</a>].</p><p>Loop diuretics act by competing for the chloride site on the Na-K-2Cl cotransporter [<a href="#rid5">5,9</a>]. Inhibiting sodium chloride reabsorption also inhibits the backleak of potassium and the generation of the lumen-positive potential. As a result, calcium excretion rises, an effect that may be exploited in the treatment of hypercalcemia in selected patients. (See  <a class="medical medical_review" href="/d/html/850.html" rel="external">"Treatment of hypercalcemia", section on 'Volume expansion with isotonic saline'</a>.)</p><p>In neonates, the calciuresis induced by a loop diuretic may be deleterious since it can lead to the development of nephrocalcinosis. (See  <a class="medical medical_review" href="/d/html/6125.html" rel="external">"Nephrocalcinosis in neonates", section on 'Pathogenesis'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">DISTAL TUBULE AND THIAZIDE DIURETICS</span><span class="headingEndMark"> — </span>Transcellular calcium transport in the distal tubule occurs through the transient receptor potential vanilloid 5 (TRPV5) channel, which facilitates calcium uptake from the tubular lumen. Extrusion of calcium from the tubular cell to the blood is driven by the Na-Ca exchanger and plasma membrane Ca-ATPase [<a href="#rid7">7</a>]. The thiazide-type diuretics decrease NaCl reabsorption in the distal tubule and connecting segment (a short segment connecting the distal and cortical collecting tubules) by inhibiting <strong>Na-Cl</strong> cotransporters in the luminal membrane that are responsible for the entry of luminal sodium and chloride into the cell (<a class="graphic graphic_figure graphicRef64975" href="/d/graphic/64975.html" rel="external">figure 2</a>) [<a href="#rid10">10,12</a>].</p><p>The diuresis induced by a thiazide diuretic may be accompanied by a fall in urinary calcium excretion of as much as 50 to 150 mg (1.3 to 3.8 mmol) per day [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Proposed mechanisms</span><span class="headingEndMark"> — </span>Two main mechanisms have been proposed to explain the effect of thiazides on calcium excretion, but their relative importance is uncertain:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased proximal sodium and water reabsorption due to volume depletion, which leads to increased passive proximal calcium reabsorption [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased distal calcium reabsorption at the thiazide-sensitive site in the distal tubule and connecting segment [<a href="#rid15">15-18</a>]. Postulated mechanisms for this effect include increased entry of luminal calcium into the tubular cell via TRPV5 in the luminal membrane, enhanced extrusion out of the tubular cell via the Na-Ca exchanger in the basolateral membrane, and decreased levels of calcium transport proteins in the kidney [<a href="#rid7">7,19-24</a>]. Although distal tubular calcium reabsorption may be increased acutely, the chronic hypocalciuric effect is probably mediated primarily by the associated volume depletion, which increases proximal sodium and therefore calcium reabsorption [<a href="#rid20">20</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Clinical implications</span><span class="headingEndMark"> — </span>The effect of thiazide diuretics on calcium balance has several important clinical implications. Perhaps most important, the hypocalciuric action probably accounts for the ability of thiazide diuretics to reduce the frequency of recurrent stone formation in patients with idiopathic hypercalciuria. (See  <a class="medical medical_review" href="/d/html/7373.html" rel="external">"Kidney stones in adults: Prevention of recurrent kidney stones"</a>.)</p><p>The fall in calcium excretion also tends to induce positive calcium balance or to minimize the degree of negative calcium balance that is commonly seen in older patients [<a href="#rid13">13</a>]. This may be manifested clinically by an increase in bone density and, in patients treated for more than two years, a reduction in the incidence of hip fracture [<a href="#rid25">25-27</a>]. The latter benefit has not been confirmed in all studies [<a href="#rid28">28</a>], although a meta-analysis suggested that long-term thiazide use led to a 20 percent reduction in fracture risk [<a href="#rid29">29</a>]. Chronic use of a loop diuretic may have the opposite effect as negative calcium balance may enhance the risk of hip fracture [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/d/html/2036.html" rel="external">"Drugs that affect bone metabolism", section on 'Thiazide diuretics'</a>.)</p><p>Thiazide diuretics also increase the plasma calcium concentration, although the effect is usually small since even slight degrees of hypercalcemia suppress parathyroid hormone (PTH) secretion [<a href="#rid13">13</a>]. In some patients, however, the plasma calcium can reach 11.5 mg/dL (2.9 mmol/L). In addition to urinary calcium retention, an increased plasma albumin concentration caused by fluid loss may contribute to thiazide-induced hypercalcemia; hyperalbuminemia increases the physiologically inactive concentration of albumin-bound calcium [<a href="#rid30">30</a>] (see  <a class="medical medical_review" href="/d/html/845.html" rel="external">"Relation between total and ionized serum calcium concentrations"</a>). Cessation of diuretic therapy in this setting leads to rapid normalization of the plasma calcium.</p><p>Underlying primary hyperparathyroidism or some other hypercalcemic state should be suspected if thiazide therapy is associated with a rise in plasma calcium above 12 mg/dL (3 mmol/L) or if hypercalcemia persists after cessation of thiazide therapy [<a href="#rid30">30,31</a>]. This was best shown in a study of 72 patients with thiazide-associated hypercalcemia [<a href="#rid31">31</a>]. Among 33 patients who discontinued the thiazide, persistent hypercalcemia was noted in 21, of whom 20 had primary hyperparathyroidism. (See  <a class="medical medical_review" href="/d/html/836.html" rel="external">"Diagnostic approach to hypercalcemia"</a>.)</p><p>Vitamin D, which is commonly given as a supplement, increases calcium absorption from the gastrointestinal tract. Combined with a thiazide, vitamin D supplements could theoretically increase the risk of hypercalcemia. The risk of the combination in subjects without other predisposing conditions, such as sarcoidosis or hyperparathyroidism, appears to be low. A post-hoc analysis of a randomized, double-blind, placebo-controlled dose-finding trial of vitamin D supplementation in community-based Black patients found that only 5.9 percent of thiazide users experienced hypercalcemia with concurrent use of <a class="drug drug_general" data-topicid="8529" href="/d/drug information/8529.html" rel="external">hydrochlorothiazide</a> and vitamin D [<a href="#rid32">32</a>]. There was no dose-response relationship (more subjects had hypercalcemia in the 1000 international unit group than in the higher-dose groups [2000 or 4000 international units] at one month) [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H6"><span class="h1">CORTICAL COLLECTING TUBULE AND POTASSIUM-SPARING DIURETICS</span><span class="headingEndMark"> — </span>Potassium-sparing diuretics act on the aldosterone-responsive distal nephron, decreasing sodium reabsorption and potassium secretion. <a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">Amiloride</a> and <a class="drug drug_general" data-topicid="10016" href="/d/drug information/10016.html" rel="external">triamterene</a> block sodium entry into the tubular cell by closing luminal <strong>sodium channels</strong> (called epithelial sodium channels). <a class="drug drug_general" data-topicid="9943" href="/d/drug information/9943.html" rel="external">Spironolactone</a> and <a class="drug drug_general" data-topicid="8789" href="/d/drug information/8789.html" rel="external">eplerenone</a> block the mineralocorticoid receptor. Amiloride increases distal calcium reabsorption and reduces urinary calcium excretion (<a class="graphic graphic_figure graphicRef60693" href="/d/graphic/60693.html" rel="external">figure 3</a>) [<a href="#rid7">7,15,18,33,34</a>].</p><p>The hypocalciuric response to <a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">amiloride</a> may involve both the connecting segment (in which sodium entry occurs via both sodium channels and thiazide-sensitive Na-Cl cotransporters in the luminal membrane) [<a href="#rid18">18</a>] and the initial cortical collecting tubule (in which sodium entry occurs only via luminal sodium channels) [<a href="#rid15">15,18,24</a>].</p><p>The mechanism by which <a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">amiloride</a> reduces calcium excretion is incompletely understood. The inhibitory effect on sodium reabsorption may hyperpolarize the membrane, thereby promoting calcium entry into the cell via calcium channels in the luminal membrane [<a href="#rid33">33</a>]. In support of this hypothesis, the increases in calcium entry and intracellular calcium activity induced by amiloride can be prevented by the calcium channel blocker, <a class="drug drug_general" data-topicid="9700" href="/d/drug information/9700.html" rel="external">nifedipine</a>, in isolated distal tubular cells.</p><p><a class="drug drug_general" data-topicid="10016" href="/d/drug information/10016.html" rel="external">Triamterene</a> has not been shown to have a hypocalciuric effect; since the drug has been shown to cause kidney stones, it should not be used to treat hypercalciuria [<a href="#rid35">35</a>]. Little is known of the effect of <a class="drug drug_general" data-topicid="9943" href="/d/drug information/9943.html" rel="external">spironolactone</a> and <a class="drug drug_general" data-topicid="8789" href="/d/drug information/8789.html" rel="external">eplerenone</a> on urinary calcium excretion in normal subjects. However, primary hyperaldosteronism is associated with increased urinary calcium excretion, secondary hyperparathyroidism, and reduced bone mineral density [<a href="#rid36">36,37</a>]; hypercalciuria is reduced by treatment with spironolactone or adrenalectomy [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H7"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Calcium reabsorption in the kidney </strong>– Most of the calcium filtered by the glomerulus is reabsorbed, an effect that occurs throughout the nephron. Calcium is reabsorbed passively in the proximal tubule and loop of Henle down the favorable electrochemical gradients created by sodium and water reabsorption. Calcium reabsorption is actively regulated according to changes in calcium balance in the distal tubule and adjacent connecting segment (a small segment between the distal tubule and cortical collecting tubule). Parathyroid hormone (PTH) and calcitriol, the most active form of vitamin D, appear to stimulate this active process. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effects of diuretics </strong>– Diuretic therapy has variable effects on urinary calcium excretion according to the site of action:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Osmotic diuretics (proximal tubule) </strong>– Calcium excretion is increased by osmotic diuretics (such as <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a>) and the carbonic anhydrase inhibitor <a class="drug drug_general" data-topicid="9268" href="/d/drug information/9268.html" rel="external">acetazolamide</a>. (See <a class="local">'Proximal tubule'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Loop diuretics (loop of Henle) </strong>– Calcium excretion is increased by loop diuretics due to diminished reabsorption. This effect may be beneficial in selected patients with hypercalcemia, but can be deleterious in neonates, leading to the development of nephrocalcinosis. (See <a class="local">'Loop of Henle and loop diuretics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Thiazide diuretics (distal tubule) </strong>– Calcium excretion is diminished by thiazide-type diuretics by as much as 50 to 150 mg (1.3 to 3.8 mmol) per day due to increased reabsorption. The fall in calcium excretion can be beneficial in certain clinical settings, reducing the frequency of new stone formation in patients with hypercalciuria and, with prolonged therapy, increasing bone density and possibly reducing the incidence of fracture. Thiazides may also cause a rise in plasma calcium, but levels above 12 mg/dL (3 mmol/L) or persistent hypercalcemia after the cessation of therapy suggests underlying primary hyperparathyroidism or some other cause of hypercalcemia. (See <a class="local">'Distal tubule and thiazide diuretics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Potassium-sparing diuretics (cortical collecting duct) </strong>– Calcium excretion is also diminished by <a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">amiloride</a> therapy, which increases calcium reabsorption. (See <a class="local">'Cortical collecting tubule and potassium-sparing diuretics'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Friedman PA, Gesek FA. Calcium transport in renal epithelial cells. Am J Physiol 1993; 264:F181.</a></li><li><a class="nounderline abstract_t">Hoenderop JG, Nilius B, Bindels RJ. Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Annu Rev Physiol 2002; 64:529.</a></li><li><a class="nounderline abstract_t">Gesek FA, Friedman PA. On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 1992; 90:749.</a></li><li><a class="nounderline abstract_t">Friedman PA, Gesek FA. Vitamin D3 accelerates PTH-dependent calcium transport in distal convoluted tubule cells. Am J Physiol 1993; 265:F300.</a></li><li><a class="nounderline abstract_t">Rose BD. Diuretics. Kidney Int 1991; 39:336.</a></li><li><a class="nounderline abstract_t">Curry JN, Saurette M, Askari M, et al. Claudin-2 deficiency associates with hypercalciuria in mice and human kidney stone disease. J Clin Invest 2020; 130:1948.</a></li><li><a class="nounderline abstract_t">Alexander RT, Dimke H. Effect of diuretics on renal tubular transport of calcium and magnesium. Am J Physiol Renal Physiol 2017; 312:F998.</a></li><li><a class="nounderline abstract_t">Edwards A, Bonny O. A model of calcium transport and regulation in the proximal tubule. Am J Physiol Renal Physiol 2018; 315:F942.</a></li><li><a class="nounderline abstract_t">Haas M. The Na-K-Cl cotransporters. Am J Physiol 1994; 267:C869.</a></li><li><a class="nounderline abstract_t">Gamba G, Miyanoshita A, Lombardi M, et al. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem 1994; 269:17713.</a></li><li><a class="nounderline abstract_t">Friedman PA. Basal and hormone-activated calcium absorption in mouse renal thick ascending limbs. Am J Physiol 1988; 254:F62.</a></li><li><a class="nounderline abstract_t">Plotkin MD, Kaplan MR, Verlander JW, et al. Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney. Kidney Int 1996; 50:174.</a></li><li><a class="nounderline abstract_t">Lemann J Jr, Gray RW, Maierhofer WJ, Cheung HS. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney Int 1985; 28:951.</a></li><li><a class="nounderline abstract_t">Nijenhuis T, Vallon V, van der Kemp AW, et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005; 115:1651.</a></li><li><a class="nounderline abstract_t">Costanzo LS. Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport. Am J Physiol 1985; 248:F527.</a></li><li><a class="nounderline abstract_t">Gesek FA, Friedman PA. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest 1992; 90:429.</a></li><li><a class="nounderline abstract_t">Lajeunesse D, Bouhtiauy I, Brunette MG. Parathyroid hormone and hydrochlorothiazide increase calcium transport by the luminal membrane of rabbit distal nephron segments through different pathways. Endocrinology 1994; 134:35.</a></li><li><a class="nounderline abstract_t">Shimizu T, Nakamura M, Yoshitomi K, Imai M. Interaction of trichlormethiazide or amiloride with PTH in stimulating Ca2+ absorption in rabbit CNT. Am J Physiol 1991; 261:F36.</a></li><li><a class="nounderline abstract_t">Friedman PA. Codependence of renal calcium and sodium transport. Annu Rev Physiol 1998; 60:179.</a></li><li><a class="nounderline abstract_t">Nijenhuis T, Hoenderop JG, Loffing J, et al. Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int 2003; 64:555.</a></li><li><a class="nounderline abstract_t">Biner HL, Arpin-Bott MP, Loffing J, et al. Human cortical distal nephron: distribution of electrolyte and water transport pathways. J Am Soc Nephrol 2002; 13:836.</a></li><li><a class="nounderline abstract_t">Hoenderop JG, van der Kemp AW, Hartog A, et al. The epithelial calcium channel, ECaC, is activated by hyperpolarization and regulated by cytosolic calcium. Biochem Biophys Res Commun 1999; 261:488.</a></li><li><a class="nounderline abstract_t">Hoenderop JG, van Leeuwen JP, van der Eerden BC, et al. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 2003; 112:1906.</a></li><li><a class="nounderline abstract_t">Bindels RJ, Ramakers PL, Dempster JA, et al. Role of Na+/Ca2+ exchange in transcellular Ca2+ transport across primary cultures of rabbit kidney collecting system. Pflugers Arch 1992; 420:566.</a></li><li><a class="nounderline abstract_t">LaCroix AZ, Wienpahl J, White LR, et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 1990; 322:286.</a></li><li><a class="nounderline abstract_t">Felson DT, Sloutskis D, Anderson JJ, et al. Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. JAMA 1991; 265:370.</a></li><li><a class="nounderline abstract_t">Cauley JA, Cummings SR, Seeley DG, et al. Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993; 118:666.</a></li><li><a class="nounderline abstract_t">Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Ann Intern Med 1991; 115:1.</a></li><li><a class="nounderline abstract_t">Jones G, Nguyen T, Sambrook PN, Eisman JA. Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res 1995; 10:106.</a></li><li><a class="nounderline abstract_t">Christensson T, Hellström K, Wengle B. Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in a health screen. Arch Intern Med 1977; 137:1138.</a></li><li><a class="nounderline abstract_t">Wermers RA, Kearns AE, Jenkins GD, Melton LJ 3rd. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med 2007; 120:911.e9.</a></li><li><a class="nounderline abstract_t">Chandler PD, Scott JB, Drake BF, et al. Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D. Am J Med 2014; 127:772.</a></li><li><a class="nounderline abstract_t">Friedman PA, Gesek FA. Stimulation of calcium transport by amiloride in mouse distal convoluted tubule cells. Kidney Int 1995; 48:1427.</a></li><li><a class="nounderline abstract_t">Harmacek D, Blanchard A, Wuerzner G, et al. Acute decrease of urine calcium by amiloride in healthy volunteers under high-sodium diet. Nephrol Dial Transplant 2022; 37:298.</a></li><li><a class="nounderline abstract_t">Ettinger B, Oldroyd NO, Sörgel F. Triamterene nephrolithiasis. JAMA 1980; 244:2443.</a></li><li><a class="nounderline abstract_t">Salcuni AS, Palmieri S, Carnevale V, et al. Bone involvement in aldosteronism. J Bone Miner Res 2012; 27:2217.</a></li><li><a class="nounderline abstract_t">Ceccoli L, Ronconi V, Giovannini L, et al. Bone health and aldosterone excess. Osteoporos Int 2013; 24:2801.</a></li></ol></div><div id="topicVersionRevision">Topic 2340 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8447431" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Calcium transport in renal epithelial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11826278" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Molecular mechanism of active Ca2+ reabsorption in the distal nephron.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1522230" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8368339" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Vitamin D3 accelerates PTH-dependent calcium transport in distal convoluted tubule cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2002648" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Diuretics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32149733" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Claudin-2 deficiency associates with hypercalciuria in mice and human kidney stone disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28274923" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Effect of diuretics on renal tubular transport of calcium and magnesium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29846115" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A model of calcium transport and regulation in the proximal tubule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7943281" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Na-K-Cl cotransporters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8021284" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2827519" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Basal and hormone-activated calcium absorption in mouse renal thick ascending limbs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8807586" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3003445" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15902302" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3985160" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1322939" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7506210" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Parathyroid hormone and hydrochlorothiazide increase calcium transport by the luminal membrane of rabbit distal nephron segments through different pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1858902" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Interaction of trichlormethiazide or amiloride with PTH in stimulating Ca2+ absorption in rabbit CNT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9558460" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Codependence of renal calcium and sodium transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12846750" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11912242" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Human cortical distal nephron: distribution of electrolyte and water transport pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10425212" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The epithelial calcium channel, ECaC, is activated by hyperpolarization and regulated by cytosolic calcium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14679186" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1614831" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Role of Na+/Ca2+ exchange in transcellular Ca2+ transport across primary cultures of rabbit kidney collecting system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2296269" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Thiazide diuretic agents and the incidence of hip fracture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984536" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8489642" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2048857" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Diuretic drug use and the risk for hip fracture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7747616" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Thiazide diuretics and fractures: can meta-analysis help?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/901082" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in a health screen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17904464" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Incidence and clinical spectrum of thiazide-associated hypercalcemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24657333" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8544399" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Stimulation of calcium transport by amiloride in mouse distal convoluted tubule cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33914065" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Acute decrease of urine calcium by amiloride in healthy volunteers under high-sodium diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7431573" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Triamterene nephrolithiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22589146" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Bone involvement in aldosteronism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23695421" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Bone health and aldosterone excess.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
